Variant report
Variant | nsv519063 |
---|---|
Chromosome Location | chr12:40536061-40538858 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:19)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:4)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:19 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CEBPB | chr12:40535738-40536586 | Hela-S3 | cervix: | n/a | n/a |
2 | ELK4 | chr12:40535775-40536082 | Hela-S3 | cervix: | n/a | n/a |
3 | EP300 | chr12:40535760-40536514 | Hela-S3 | cervix: | n/a | n/a |
4 | FOS | chr12:40535878-40536234 | MCF10A-Er-Src | breast: | n/a | chr12:40536080-40536090 chr12:40536080-40536090 chr12:40536080-40536090 |
5 | FOS | chr12:40535923-40536440 | MCF10A-Er-Src | breast: | n/a | chr12:40536080-40536090 chr12:40536080-40536090 chr12:40536080-40536090 |
6 | FOS | chr12:40535923-40536458 | MCF10A-Er-Src | breast: | n/a | chr12:40536080-40536090 chr12:40536080-40536090 chr12:40536080-40536090 |
7 | FOSL2 | chr12:40535957-40536483 | A549 | lung: | n/a | chr12:40536080-40536090 chr12:40536080-40536090 chr12:40536080-40536090 |
8 | MAX | chr12:40535776-40536501 | Hela-S3 | cervix: | n/a | n/a |
9 | MAX | chr12:40538008-40538106 | Hela-S3 | cervix: | n/a | chr12:40538038-40538048 |
10 | MAX | chr12:40537893-40538124 | NB4 | blood: | n/a | chr12:40537980-40537990 chr12:40538038-40538048 |
11 | RCOR1 | chr12:40535838-40536465 | Hela-S3 | cervix: | n/a | n/a |
12 | SPI1 | chr12:40537924-40538060 | K562 | blood: | n/a | n/a |
13 | SPI1 | chr12:40537766-40538271 | HL-60 | blood: | n/a | n/a |
14 | STAT3 | chr12:40535900-40536502 | Hela-S3 | cervix: | n/a | chr12:40536151-40536158 |
15 | STAT3 | chr12:40536256-40536289 | MCF10A-Er-Src | breast: | n/a | n/a |
16 | TCF7L2 | chr12:40535934-40536502 | Hela-S3 | cervix: | n/a | chr12:40536081-40536090 |
17 | TCF7L2 | chr12:40535875-40536436 | Hela-S3 | cervix: | n/a | chr12:40536081-40536090 |
18 | USF2 | chr12:40535835-40536102 | Hela-S3 | cervix: | n/a | n/a |
19 | ZKSCAN1 | chr12:40535779-40536654 | Hela-S3 | cervix: | n/a | n/a |
No data |
(count:2 , 50 per page) page:
1
(count:4 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-SLC2A13-1 | chr12:40534259-40536436 | XLOC_010052 |
2 | lnc-SLC2A13-1 | chr12:40537983-40538106 | XLOC_010052 |
3 | lnc-SLC2A13-1 | chr12:40534728-40536678 | ENSG00000260943.1 |
4 | lnc-SLC2A13-1 | chr12:40537621-40538106 | XLOC_010052 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000260943 | TF binding region |
BRMS1L | miRNA target sites |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs726330 | chr12:40536061-40536062 | Weak transcription Enhancers | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs566321432 | chr12:40536079-40536080 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
3 | rs533783619 | chr12:40536128-40536129 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
4 | rs190526186 | chr12:40536222-40536223 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
5 | rs577301257 | chr12:40536267-40536268 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
6 | rs138130630 | chr12:40536274-40536275 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
7 | rs535780666 | chr12:40536314-40536315 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
8 | rs535972418 | chr12:40536315-40536316 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
9 | rs373924727 | chr12:40536317-40536318 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
10 | rs556541773 | chr12:40536329-40536330 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
11 | rs370090731 | chr12:40536333-40536334 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
12 | rs574984389 | chr12:40536408-40536409 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
13 | rs183096480 | chr12:40536452-40536453 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
14 | rs17442735 | chr12:40536470-40536471 | Weak transcription Enhancers | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs372511036 | chr12:40536482-40536483 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
16 | rs572671291 | chr12:40536505-40536506 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
17 | rs75881506 | chr12:40536506-40536507 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
18 | rs7306099 | chr12:40536513-40536514 | Weak transcription Enhancers | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
19 | rs2638223 | chr12:40536581-40536582 | Weak transcription Enhancers | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs142022962 | chr12:40536612-40536613 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
21 | rs562514776 | chr12:40536638-40536639 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
22 | rs529681839 | chr12:40536640-40536641 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
23 | rs188110851 | chr12:40536643-40536644 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
24 | rs7294643 | chr12:40536678-40536679 | Weak transcription Enhancers | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
25 | rs2708460 | chr12:40536689-40536690 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs551967903 | chr12:40536760-40536761 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs570827523 | chr12:40536826-40536827 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs192718140 | chr12:40536843-40536844 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs17442742 | chr12:40536845-40536846 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
30 | rs530733332 | chr12:40536916-40536917 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs556241885 | chr12:40536936-40536937 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs183444198 | chr12:40536939-40536940 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs554277048 | chr12:40536973-40536974 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs146340499 | chr12:40537040-40537041 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs17442749 | chr12:40537046-40537047 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
36 | rs572795159 | chr12:40537060-40537061 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs546393053 | chr12:40537089-40537090 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs12228200 | chr12:40537144-40537145 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs113986209 | chr12:40537163-40537164 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs2638222 | chr12:40537203-40537204 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
41 | rs187560355 | chr12:40537377-40537378 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs7484475 | chr12:40537450-40537451 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
43 | rs562490600 | chr12:40537460-40537461 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs141954302 | chr12:40537506-40537507 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs7306718 | chr12:40537656-40537657 | Weak transcription | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
46 | rs200172435 | chr12:40537705-40537706 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
47 | rs75408137 | chr12:40537706-40537707 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
48 | rs559980511 | chr12:40537718-40537719 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
49 | rs2253171 | chr12:40537828-40537829 | Weak transcription | TF binding regionlncRNA | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs552038335 | chr12:40537834-40537835 | Weak transcription | TF binding regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Chronic lymphocytic leukemia | 21546498 | CNVD |
Seminomas | 18059402 | CNVD |
Wilms tumour | 21544195 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Chronic lymphocytic leukemia | 21670202 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Autism | 22495311 | CNVD |
Cancer | 20164919 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Breast cancer | 21949216 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 21637783 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 17603634 | CNVD |
Cancer | 21183584 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Lissencephaly | 21572526 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Autism | 20858243 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Breast cancer | 19602461 | CNVD |
Breast cancer | 17899364 | CNVD |
Cancer | 20164920 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Breast cancer | 21364760 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr12:40532800-40543800 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
2 | chr12:40535000-40537200 | Enhancers | Hela-S3 | cervix |
3 | chr12:40535600-40536600 | Enhancers | HMEC | breast |
4 | chr12:40535600-40536600 | Enhancers | NHEK | skin |
5 | chr12:40535800-40536400 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
6 | chr12:40535800-40536400 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
7 | chr12:40536000-40536600 | Enhancers | Placenta Amnion | Placenta Amnion |